SLI
2.063,54
PKT
-19,20
PKT
-0,92
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
09.04.21 | Holcim kaufen | DZ BANK | |
09.04.21 | Holcim Hold | Jefferies & Company Inc. | |
09.04.21 | Holcim overweight | JP Morgan Chase & Co. | |
09.04.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
09.04.21 | Holcim kaufen | Barclays Capital | |
09.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
09.04.21 | UBS Equal-Weight | Morgan Stanley | |
09.04.21 | Givaudan buy | UBS AG | |
08.04.21 | Nestlé buy | Goldman Sachs Group Inc. | |
07.04.21 | Holcim overweight | Morgan Stanley | |
07.04.21 | Swiss Re buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.04.21 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
07.04.21 | UBS Neutral | UBS AG | |
07.04.21 | UBS Neutral | Goldman Sachs Group Inc. | |
07.04.21 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
07.04.21 | UBS Outperform | Credit Suisse Group | |
07.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
07.04.21 | UBS Sector Perform | RBC Capital Markets | |
06.04.21 | UBS Neutral | JP Morgan Chase & Co. | |
06.04.21 | Givaudan Sell | Goldman Sachs Group Inc. | |
06.04.21 | UBS Halten | DZ BANK | |
06.04.21 | UBS Sector Perform | RBC Capital Markets | |
06.04.21 | UBS overweight | JP Morgan Chase & Co. | |
06.04.21 | UBS kaufen | JP Morgan Chase & Co. | |
06.04.21 | ABB (Asea Brown Boveri) buy | Goldman Sachs Group Inc. | |
31.03.21 | UBS Neutral | UBS AG | |
31.03.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
30.03.21 | Nestlé overweight | JP Morgan Chase & Co. | |
30.03.21 | UBS Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
30.03.21 | Zurich Insurance overweight | Barclays Capital | |
30.03.21 | UBS Neutral | Goldman Sachs Group Inc. | |
29.03.21 | Givaudan Hold | Deutsche Bank AG | |
29.03.21 | UBS kaufen | DZ BANK | |
26.03.21 | Nestlé buy | Goldman Sachs Group Inc. | |
25.03.21 | Holcim Hold | Jefferies & Company Inc. | |
25.03.21 | UBS Outperform | Credit Suisse Group | |
24.03.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
24.03.21 | Roche overweight | Barclays Capital | |
24.03.21 | Roche Neutral | JP Morgan Chase & Co. |